1-4 of 4
Shira N. Dinner, MD
Close
Sort by
Journal Articles

Disease Characteristics and Prognosis of Myelodysplastic Syndrome Presenting with Isolated Thrombocytopenia

Julie B Waisbren, MD, Shira N. Dinner, MD, Irene Helenowski, PhD, Juehua Gao, MDPhD, Brandon McMahon, MD, Brady Stein, MD
Journal: Blood
Blood (2015) 126 (23): 3477.
https://doi.org/10.1182/blood.V126.23.3477.3477
Published: 2015
Journal Articles

Amrubicin, a Novel Investigational Anthracycline, in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

Shira N. Dinner, MD, Tamara J. Dunn, MD, Bruno C. Medeiros, MD, Steven E. Coutre, MD, Caroline Berube, MD, Jason Gotlib, M.D., M.S., Michaela Liedtke, MD
Journal: Blood
Blood (2012) 120 (21): 4027.
https://doi.org/10.1182/blood.V120.21.4027.4027
Published: 2012
Journal Articles

A Phase I/II Study of Bortezomib (VELCADE) in Combination with Pralatrexate in Relapsed/Refractory Multiple Myeloma

Tamara J. Dunn, MD, Shira N. Dinner, MD, Caroline Berube, MD, Jason Gotlib, MD, MS, Steven E. Coutre, MD, Bruno C. Medeiros, MD, Michaela Liedtke, MD
Journal: Blood
Blood (2012) 120 (21): 4304.
https://doi.org/10.1182/blood.V120.21.4304.4304
Published: 2012
Journal Articles

Biomarkers To Predict Outcome after Allogeneic Hematopoietic Cell Transplant (HCT).

Shira N. Dinner, MD, Andrew Artz, MD, MS, Masha Kocherginsky, PhD, Jodie Ulaszek, MS, Daniel Pollyea, MD, Lucy Godley, MD, PhD, Richard A. Larson, MD, Olatoysi Odenike, MD, Elizabeth Rich, MD, PhD, Wendy Stock, MD, Koen van Besien, MD, Amittha Wickrema, PhD
Journal: Blood
Blood (2007) 110 (11): 1100.
https://doi.org/10.1182/blood.V110.11.1100.1100
Published: 2007